Pancreatic cancer
Immunotherapy can be a first-line cancer treatment for patients with pancreatic cancer and FDA currently approves one immunotherapy treatment for people having pancreatic cancer and further research is still going on. Following is the one immunotherapy treatment for pancreatic cancer:
Immunomodulators:
- Pembrolizumab
Pembrolizumab is one of the checkpoint inhibitors that kills the cancer cells on PD-1/PD-L1 pathway and can treat the patients with advanced pancreatic cancer. Pembrolizumab is a great option for advanced pancreatic patients that have increased microsatellite instability (MSI-H), high tumor mutational burden (TMB-H), and DNA mismatch repair deficiency (dMMR).